CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Panacea Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Panacea Inc
204, 4 Ba, 39, Beonnyeong-ro, Danwon-gu
Phone: +82 314958262p:+82 314958262 ANSAN, 15616  South Korea Fax: +82 316282626f:+82 316282626

This company is no longer actively traded on any major stock exchange.

Business Summary
Panacea Inc, formerly Supex BNP Co Ltd, is a Korea-based company mainly engaged in the distribution business. The Company mainly operates its business through two segments. The Distribution Business segment is mainly engaged in the sale of sports clothing and footwear, cosmetics, foods and others. The Automation Business segment is mainly engaged in the manufacture and sale of loaders, bonding machines, high frequency bonding machines, lay-up systems, trimming machines, X-radiation (X-ray) machines and others. In addition, the Company is also engaged in the real estate rental business.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/202412/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Director Bang HunCheon 66 9/1/2023 9/2/2022
Internal Auditor Bo SeopMaeng 53
Director Nam YongLee 65
4 additional Officers and Directors records available in full report.

Business Names
Business Name
058530
EQUISnZAROO CO.,LTD
EQUISPHARM Co., Ltd.
Hansong Hitech Co., Ltd.
Onkor Pharmaceuticals. Inc.

General Information
Number of Employees: 100 (As of 12/31/2015)
Outstanding Shares: 20,075,081 (As of 3/31/2024)
Shareholders: 11,999
Stock Exchange: KDQ
Fax Number: +82 316282626


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 20, 2024